be_ixf;ym_202604 d_28; ct_50

Latest Insights on SEV

As we head into the second half of the year, the risks I foresaw in December are still there. But so are the opportunities for smart profits. Make Smart Profits in 2019’s Market Downturn July 3, 2019 by Ted Bauman Stocks, Trading Strategies, Winning Investor Daily As we head into the second half of the year, the risks I foresaw in December are still there. But so are the opportunities for smart profits.
Great Stuff 6-28-2019 G-20 Weekend: 4 Things You Need to Know June 28, 2019 by Joseph Hargett Great Stuff It’s G-20 weekend! Aren’t you excited? World leaders are gathering in Osaka, Japan, to discuss how best to take advantage of each other and you, the investor. It’s kind of like Family Feud, except on a global scale. For a closer look at this growing kerfuffle, here’s your Friday Four Play: Russian President Vladimir Putin […]
Great Stuff 6-27-2019 Bitcoin’s Crypto Bubble, Thanks to Facebook Libra June 27, 2019 by Joseph Hargett Great Stuff Today, we’re not going to talk about Trump, China or the Democratic debates. You’re welcome. The reason: I’m plumb Xi’ed out. I’ve got no more Trump in the tank, and it’s far too early to worry about what the two million candidates running for the Democratic nomination are debating right now. Besides, bitcoin (CCC: BTC-USD) […]
ROBO ETF Is a Great Way to Invest in the Emerging Tech Revolution June 27, 2019 by Charles Mizrahi American Investor Today, Investment Opportunities, Technology Electricity changed the world forever. It would be very difficult for our modern society to exist without it. Nowadays, there is a new trend that’s already changing our way of living. Charles Mizrahi has a close eye on this profitable sector. (3-minute read)
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“Loving this. Should have started a long time ago.”

- Jay

Share This